2-Bromo-4,5-methylenedioxyamphetamine

2-Bromo-4,5-methylenedioxyamphetamine
Names
Preferred IUPAC name
1-(6-Bromo-2H-1,3-benzodioxol-5-yl)propan-2-amine
Other names
2-Bromo-4,5-methylenedioxyamphetamine
2-(2-Bromo-4,5-methylenedioxyphenyl)ethan-1-methyl-amine
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C10H12BrNO2/c1-6(12)2-7-3-9-10(4-8(7)11)14-5-13-9/h3-4,6H,2,5,12H2,1H3 checkY
    Key: PHCFFGXVMHXBGD-UHFFFAOYSA-N checkY
  • InChI=1/C10H12BrNO2/c1-6(12)2-7-3-9-10(4-8(7)11)14-5-13-9/h3-4,6H,2,5,12H2,1H3
    Key: PHCFFGXVMHXBGD-UHFFFAOYAH
  • Brc1cc2c(OCO2)cc1CC(C)N
  • CC(Cc1cc2c(cc1Br)OCO2)N
Properties
C11H17BrNO2
Molar mass 275.166 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Infobox references

6-Bromo-MDA, also known as 2-bromo-4,5-methylenedioxyamphetamine (2-Br-4,5-MDA) is a lesser-known psychedelic drug and a substituted amphetamine. It was first synthesized by Alexander Shulgin. In his book PiHKAL, the dose is listed as 350 mg and the duration unknown.[1] It produces stimulant effects but with no psychedelic or entactogenic effects.[1] Very little data exists about its pharmacological properties, metabolism, and toxicity.

See also

References

  1. ^ a b 2-Bromo-4,5-methylenedioxyamphetamine entry in PiHKAL


This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.